Investments
Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision and ambition for commercial growth. ...
April 2024 - Monthly House Views - Central banks out-of-sync
Recent data from the US have surprised on the upside for both inflation and the economic growth, raising fears the Fed may rethink its rate cuts. Meanwhile, renewed tensions in the Middle East are unnerving already jittery markets. Despite these concerns, we stand by our scenario of pos...
Cambridge Index drops 3.9%
The Cambridge Index dropped 732.21 points or 3.9% to close at 17,813.0, as four out of the top ten index heavyweights posted weekly losses in their share price. ...
March 2024 - Monthly House Views - Different Rhythms
All regions are growing but all at very different tempos. The US economy continues to grow a particularly strong pace whilst the euro area and United Kingdom are marching to a slower beat. In these regions, labour markets are looking healthy and easing inflation is providing a welcome b...
February 2024 - Monthly House Views - The Last Mile
Inflation fell sharply in 2023 but remains above the central banks’ 2% target and the “last mile” could prove a long haul. Resilient economies with robust labour markets are keeping up the pressure on wages and hence prices. In these circumstances, central banks are likely to cut rates ...
January 2024 - Monthly House Views - 2024: Back to Normal?
Hopes for big central bank rate cuts in 2024 underpinned the sharp rally of nearly all asset classes at the end of 2023, making good much of the decline seen in 2022. Investors believe the worst period of inflation is now behind us and price pressures and monetary policy are moving back...
Cambridge Index rises 1.2%
The Cambridge Index rose 216.94 points or 1.2% to close at 18,545.2, as six out of the top ten index heavyweights posted weekly gains in their share price. ...
Healx to receive investment from Children’s Tumor Foundation to advance Neurofibromatosis Type 1 treatments
Cambridge, UK - Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery, announces that it has signed an investment agreement with its long-term partner, Children’s Tumor Foundation (CTF). Milestone-driven payments from CTF will support...
Cambridge Index advances 1.2%
The Cambridge Index rose 217.50 points or 1.2% to close at 18,328.3, as five out of the top ten index heavyweights posted weekly gains in their share price. ...
Business confidence up and uncertainty down for UK CFOs
Sentiment among UK CFOs has risen for the third consecutive quarter; Uncertainty has fallen to a two-and-a-half-year low, back to levels seen in summer 2021 when lockdown restrictions were ending; Corporate risk appetite has risen, but CFOs maintain a defensive strategy stance; Cyber...